newsfilter
← Latest News
Business Wire·

Sesen Bio Reports Second Quarter 2022 Financial Results and Business Update

Company continues to assess potential strategic alternatives with the goal of maximizing shareholder value Strong balance sheet of $161 million in cash, cash equivalents and marketable securities as of June 30, 2022 Sesen Bio (NASDAQ:SESN) today